ScholarIQanswers from OpenAlex & ORCID
David A. Roth
ResearcherPublications, citations & collaboration network
David A. Roth is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does David A. Roth have?
ScholarIQindexed works
David A. Roth has 284 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does David A. Roth have?
ScholarIQcitation count
David A. Roth has 26,899 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of David A. Roth?
ScholarIQh-index
David A. Roth has an h-index of 55 in OpenAlex.
What is the i10-index of David A. Roth?
ScholarIQi10-index
David A. Roth has an i10-index of 132 in OpenAlex.
What is the ORCID of David A. Roth?
ScholarIQorcid
The ORCID for David A. Roth is on the source record.
What is the OpenAlex record for David A. Roth?
ScholarIQopenalex
The OpenAlex for David A. Roth is on the source record.
What are the most-cited papers on David A. Roth?
ScholarIQmost cited works
A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation
Andrew S. Levey, Juan Bosch, Julia B. Lewis, Tom Greene, Nancy Rogers, David A. Roth, for the Modification of Diet in Renal Disease Study Group*
Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis
Richard Furie, Brad H. Rovin, Frédéric Houssiau, Ana Malvar, Y K Onno Teng, Gabriel Contreras, Zahir Amoura, Xueqing Yu, Chi-Chiu Mok, Mittermayer B. Santiago, Amit Saxena, Yulia Green, Beulah Ji, C. Kleoudis, Susan W. Burriss, Carly Barnett, David A. Roth
Sequential Therapies for Proliferative Lupus Nephritis
Gabriel Contreras, Victoriano Pardo, Baudouin Leclercq, Oliver Lenz, Elaine Tozman, Patricia O'Nan, David A. Roth
The evaluation of renal transplantation candidates: clinical practice guidelines.
Bertram L. Kasiske, Charles B. Cangro, Sundaram Hariharan, Dondald E Hricik, Ronald H. Kerman, David A. Roth, David N. Rush, Miguel A. Vazquez, Matthew R. Weir
Efficacy and Safety of Subcutaneous Belimumab in Systemic Lupus Erythematosus: A Fifty‐Two–Week Randomized, Double‐Blind, Placebo‐Controlled Study
William Stohl, Andreas Schwarting, Masato Okada, Morton Scheinberg, Andrea Doria, Anne E. Hammer, C. Kleoudis, James Groark, Damon Bass, Norma Lynn Fox, David A. Roth, David Gordon